Lipella Pharmaceuticals Inc
OTC:LIPO
Lipella Pharmaceuticals Inc
OTC:LIPO
Price:
0.0006
USD
20%
Market Closed
Market Cap:
$2.8k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lipella Pharmaceuticals Inc
OTC:LIPO
|
US |
|
D
|
Duke Energy Corp
XHAM:D2MN
|
US |
|
C
|
Corporate Travel Management Ltd
F:1C6
|
AU |
|
Euronet Worldwide Inc
F:EEF
|
US |
|
F
|
Fresenius SE & Co KGaA
XMUN:FRE
|
DE |
|
M
|
MacroAsia Corp
XPHS:MAC
|
PH |
|
C
|
China Travel International Investment Hong Kong Ltd
OTC:CTVIF
|
HK |
|
Meko AB
F:1OM
|
SE |
|
Sika AG
OTC:SKFOF
|
CH |
|
MillerKnoll Inc
F:MHR
|
US |
|
Mizuno Corp
F:MIZ
|
JP |
|
Kering SA
F:PPXB
|
FR |
|
I
|
IAMGOLD Corp
XMUN:IAL
|
CA |
|
S
|
Sirius XM Holdings Inc
F:3HY
|
US |
Intrinsic Value
Not Available for LIPO
There is not enough data to reliably calculate the intrinsic value for Lipella Pharmaceuticals Inc.
Do our valuations actually work? See backtest results .
Alternatives to LIPO
Fundamental Analysis
What Lipella Pharmaceuticals Does
Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 4 full-time employees. The company went IPO on 2022-12-20. The firm is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications.
- Headquarters
- United States of America US
- Employees
- 4
- IPO date
- Dec 20, 2022
Financials
Efficiency
Earnings Waterfall
Lipella Pharmaceuticals Inc
Lipella Pharmaceuticals Inc
